SCHEMBL14418367

SCHEMBL14418367

Cc1cc(-c2ccc(/N=N/c3c(N)c(S(=O)(=O)O)cc4cc(S(=O)(=O)O)ccc34)c(C)c2)ccc1/N=N/c1cc(S(=O)(=O)O)c2ccccc2c1N

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ENPP2 Q13822 4/20 1.00
▸ SENP2 Q9HC62 5/20 0.76
▸ SENP1 Q9P0U3 5/20 0.76
▸ SUMO2 P61956 4/20 0.76
▸ SUMO1 P63165 4/20 0.76
▸ SENP7 Q9BQF6 4/20 0.76
▸ SENP3 Q9H4L4 3/20 0.76
▸ PHLPP2 Q6ZVD8 2/20 0.61
▸ ALDH1A1 P00352 5/20 0.59
▸ THRB P10828 4/20 0.59
▸ HPGD P15428 3/20 0.59
▸ RECQL P46063 3/20 0.59
▸ ALOX12 P18054 2/20 0.59
▸ CYP3A4 P08684 2/20 0.59
▸ ALOX15 P16050 2/20 0.59
▸ TSHR P16473 2/20 0.59
▸ MAPK1 P28482 2/20 0.59
▸ HSD17B10 Q99714 2/20 0.59
▸ HIF1A Q16665 2/20 0.58
▸ MEN1 O00255 4/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7804546 1.00 ENPP2 (1.00) ENPP2SENP2SENP1SUMO2SUMO1
SCHEMBL14418523 0.87 SUMO2 (1.00) ENPP2SENP2SENP1SUMO2SUMO1
SCHEMBL29374866 0.87 SUMO2 (1.00) ENPP2SENP2SENP1SUMO2SUMO1
SCHEMBL19154084 0.85 SENP2 (0.79) ENPP2SENP2SENP1SUMO2SUMO1
SCHEMBL11922531 0.85 SENP2 (0.79) ENPP2SENP2SENP1SUMO2SUMO1
SCHEMBL19132211 0.81 SENP2 (0.69) ENPP2SENP2SENP1SUMO2SUMO1
SCHEMBL19132261 0.81 SENP2 (0.78) ENPP2SENP2SENP1SUMO2SUMO1
SCHEMBL14413371 0.79 SUMO2 (0.86) ENPP2SENP2SENP1SUMO2SUMO1
SCHEMBL4952032 0.79 SUMO2 (0.86) ENPP2SENP2SENP1SUMO2SUMO1
SCHEMBL23787708 0.78 SENP2 (0.74) ENPP2SENP2SENP1SUMO2SUMO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7264932-B2 Nuclease inhibitor cocktail APPLERA CORPORATION (US) 2007-09-04 — — US disclosed
US-20070032418-A1 Small-molecule inhibitors of angiogenin and rnases and in vivo and in vitro methods of using same AMBION, INC (US) 2007-02-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070032418-A1 Small-molecule inhibitors of angiogenin and rnases and in vivo and in vitro methods of using same RNASE1, RNASEH1, RNASEL ENPP2 932/4885SENP2 672/4885SENP1 746/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback